King’s Medal Awarded to Canadian Neuromuscular Clinicans and Researchers
We are incredibly proud to share that several NMD4C investigators and collaborators from the Canadian neuromuscular community have been awarded a King Charles III’s Coronation Medal in recognition of their outstanding contributions and service in the neuromuscular field. This prestigious honour highlights their dedication, resilience, and impact in making a difference in the lives of people affected by NMDs.
We are pleased to congratulate the remarkable individuals, who received this recognition through nominations from Muscular Dystrophy Canada and the ALS Society of Canada for their outstanding achievements in the neuromuscular field, including NMD4C investigators and collaborators Drs Bernard Brais, Cynthia Gagnon, Rashmi Kothary, Lawrence Korngut, Alex MacKenzie, Colleen O’Connell, Kerri Schellenberg, Christen Shoesmith, Lorne Zinman, Robin Parks, and Guy Rouleau.
Read next...
Scheduled Maintenance
Please note that this website, imPORTND, and the NNLS training platform will undergo maintenance from July 23 until July 27, 2026.
Discover Neuromuscular Talent Across Canada
The NMD4C Neuromuscular Talent Pool is now live with new trainees! We invite supervisors and research groups to explore the Talent Pool to identify candidates whose skills, experience, and interests align with your work and upcoming positions. Trainees interested in being included in the Neuromuscular Talent Pool can register by completing the short form, uploading a CV and brief personal statement outlining their experience, interests, and career goals. For more information and to access the Talent Pool, please visit our website.
Join Us at the 2026 NMD4C Annual Meeting on 25 September
The 2026 NMD4C Annual Meeting will take place in Calgary on Friday, September 25, 2026. The agenda will feature a brief network update, trainee and early-career recognitions, flash talks, a health economics research showcase, and a series of cross‑disciplinary and parallel clinical/pre‑clinical discussion sessions to explore key topics, including advocacy and therapy access, strategies to sustain and strengthen pre-clinical programs, and network sustainability and strategic planning.